Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort
- PMID: 35366359
- PMCID: PMC9324151
- DOI: 10.1111/jdv.18124
Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort
Abstract
Background: Mohs micrographic surgery (MMS) is a precise, tissue-sparing surgical technique that offers superior cure rates compared to traditional surgical excision. However, the degree of difficulty of MMS depends on many variables, and consequently, the number of surgical stages required for each case is quite unpredictable.
Objectives: To identify risk factors for complicated MMS, defined as MMS requiring ≥3 stages.
Methods: In a cohort study design, data were prospectively collected from 612 patients that underwent MMS for basal cell carcinoma (BCC) at the Department of Dermatology, Skåne University Hospital, Lund, between 2009 and 2020. Univariate and multivariate logistic regression were used to estimate the risk of MMS requiring ≥3 stages. Due to the risk of multicollinearity between recurrent or incompletely excised BCC and previous treatments, a partially and a fully adjusted multivariate logistic regression model were constructed.
Results: In fully adjusted multivariate analyses, age (odds ratio (OR) 1.02; confidence interval (CI) 95% 1.00-1.04), previous cryotherapy (OR 2.3; CI 95% 1.1-4.8), and >1 previous surgery (OR 3.4; CI 95% 1.5-7.7) were significantly associated with risk of complicated MMS. Recurrent BCC was associated with the risk of complicated MMS in partially adjusted multivariate analyses, but not in the fully adjusted analyses. In this highly selected cohort, histopathological subtype, and tumour localization were not associated with the risk of complicated MMS.
Conclusions: Older age and tumours previously treated with cryotherapy or multiple prior surgeries increased the risk of MMS requiring ≥3 stages. Whether recurrent BCC is an independent risk factor for complicated MMS needs further evaluation. Knowledge of these risk factors may ameliorate the planning of Mohs surgeries.
© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Similar articles
-
Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.Clin Otolaryngol. 2018 Oct;43(5):1321-1327. doi: 10.1111/coa.13176. Epub 2018 Jul 19. Clin Otolaryngol. 2018. PMID: 29953746
-
Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.J Dermatolog Treat. 2019 Feb;30(1):74-80. doi: 10.1080/09546634.2018.1468868. Epub 2018 May 10. J Dermatolog Treat. 2019. PMID: 29727201
-
Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.An Bras Dermatol. 2022 May-Jun;97(3):291-297. doi: 10.1016/j.abd.2021.08.007. Epub 2022 Apr 2. An Bras Dermatol. 2022. PMID: 35379511 Free PMC article.
-
Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.Br J Dermatol. 2004 Jul;151(1):141-7. doi: 10.1111/j.1365-2133.2004.06047.x. Br J Dermatol. 2004. PMID: 15270883 Review.
-
Mohs' micrographic surgery for basal cell carcinoma.Clin Exp Dermatol. 1999 Mar;24(2):130-3. doi: 10.1046/j.1365-2230.1999.00433.x. Clin Exp Dermatol. 1999. PMID: 10233670 Review.
Cited by
-
Features associated with the use of single or combined reconstructions: analysis of 1,124 Mohs surgeries.An Bras Dermatol. 2025 Mar-Apr;100(2):342-345. doi: 10.1016/j.abd.2024.07.009. Epub 2025 Jan 31. An Bras Dermatol. 2025. PMID: 39893140 Free PMC article. No abstract available.
References
-
- Lomas A, Leonardi‐Bee J, Bath‐Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–1080. - PubMed
-
- Kappelin J, Green AC, Ingvar Å, Ahnlide I, Nielsen K. Incidence and trends of basal cell carcinoma in Sweden: a population‐based registry study. Br J Dermatol 2022; 186: 963–969. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical